Dr Faraz Ali

2024

• Shah, R., Salek, M., Ali, F., Nixon, S., Otwombe, K., Ingram, J. and Finlay, A. 2024. Dementia and its profound Impact on family members and partners. Alzheimer Disease & Associated Disorders 38(4), pp. 338-342. (10.1097/WAD.0000000000000647)
• Shah, R. et al. 2024. Comparison of the impact of type 1 and type 2 diabetes on quality of life of families of patients: A UK cross‐sectional study. Diabetes, Obesity and Metabolism (10.1111/dom.16058)
• Vyas, J., Johns, J. R., Ali, F. M., Ingram, J. R., Salek, S. and Finlay, A. Y. 2024. A systematic review of 207 studies describing validation aspects of the dermatology life quality index. Acta Dermato-Venereologica 104, article number: adv41120. (10.2340/actadv.v104.41120)
• Johns, J. R., Vyas, J., Ali, F. M., Ingram, J. R., Salek, S. and Finlay, A. Y. 2024. The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review. British Journal of Dermatology 191(4), pp. 497-507. (10.1093/bjd/ljae228)
• Vyas, J., Johns, J., Abdelrazik, Y., Ali, F., Ingram, J., Salek, S. and Finlay, A. 2024. The Dermatology Life Quality Index (DLQI) used as the benchmark in validation of 101 quality of life instruments: A systematic review. Journal of the European Academy of Dermatology and Venereology (10.1111/jdv.20321)
• Shah, R. et al. 2024. Measurement of the major ignored burden of multiple myeloma, pernicious anaemia and of other haematological conditions on partners and family members: A cross‐sectional study. European Journal of Haematology 113(1), pp. 117-126. (10.1111/ejh.14206)
• Shah, R. et al. 2024. Mapping of family reported outcome measure (FROM-16) scores to EQ-5D: algorithm to calculate utility values. Quality of Life Research 33, pp. 1107-1119. (10.1007/s11136-023-03590-z)
• Vyas, J., Johns, J. R., Ali, F. M., Singh, R. K., Ingram, J. R., Salek, S. and Finlay, A. Y. 2024. A systematic review of 457 randomised controlled trials using the Dermatology Life Quality Index: experience in 69 diseases and 43 countries. British Journal of Dermatology 190(3), pp. 315-339. (10.1093/bjd/ljad079)

2023

• Pawlak, Z., Krajewski, P., Wójcik, E., Stefaniak, A., Ali, F. M., Finlay, A. Y. and Szepietowski, J. 2023. Translation and validation of the Polish language version of the Teenagers Quality of Life questionnaire (T-QoL). Postępy Dermatologii i Alergologii 40(6), pp. 753-756. (10.5114/ada.2023.133584)
• Shah, R., Finlay, A. Y., Salek, S. M., Nixon, S. J., Otwombe, K., Ali, F. M. and Ingram, J. R. 2023. Meaning of Family Reported Outcome Measure (FROM-16) severity score bands: a cross-sectional online study in the UK. BMJ Open 13(3), article number: e066168. (10.1136/bmjopen-2022-066168)

2021

• Abdelrazik, Y. T., Ali, F. M., Salek, M. S. and Finlay, A. Y. 2021. Clinical experience and psychometric properties of the Cardiff Acne Disability Index (CADI). British Journal of Dermatology 185(4), pp. 711-724. (10.1111/bjd.20391)
• Bardazzi, F. et al. 2021. The impact of psoriasis on quality of life of children and their caregivers: an Italian experience. European Journal of Dermatology 31(5), pp. 649-650. (10.1684/ejd.2021.4127)
• Shah, R., Ali, F. M., Finlay, A. Y. and Salek, M. S. 2021. Family reported outcomes, an unmet need in the management of a patient's disease: appraisal of the literature. Health and Quality of Life Outcomes 19, article number: 194. (10.1186/s12955-021-01819-4)
• Shah, R., Ali, F. M., Nixon, S. J., Ingram, J. R., Salek, S. M. and Finlay, A. Y. 2021. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open 11(5), article number: e047680. (10.1136/bmjopen-2020-047680)
• Ali, F. M. 2021. Evaluating quality of life measurement in psoriasis and the development of new solutions to improve the use of patient-reported outcomes. PhD Thesis, Cardiff University.
• Wójcik, E. et al. 2021. Major life changing decision profile: Creation of the Polish language version. Dermatologic Therapy 34(1), article number: e14568. (10.1111/dth.14568)

2020

• Ali, F., Vyas, J. and Finlay, A. Y. 2020. Counting the burden: atopic dermatitis and health-related quality of life. Acta Dermato-Venereologica 100(12), article number: adv00161. (10.2340/00015555-3511)
• Hasan, S., Ali, F. and Ingram, J. 2020. Cholinergic pruritus responding to Omalizumab. Clinical and Experimental Dermatology 45(2), pp. 264-266. (10.1111/ced.14052)

2019

• Ali, F., Salek, M., Finlay, A. and Piguet, V. 2019. Validation of the electronic Psoriasis Area and Severity Index application: establishing measurement equivalence. Journal of The American Academy of Dermatology 81(6), pp. 1439-1441. (10.1016/j.jaad.2019.04.073)

2018

• Ali, F., Johns, N., Salek, S. and Finlay, A. 2018. Correlating the Dermatology Life Quality Index with psychiatric measures: A systematic review. Clinics in Dermatology 36(6), pp. 691-697. (10.1016/j.clindermatol.2018.08.014)
• Ali, F., Salek, M. S. and Finlay, A. 2018. Two minimal clinically important difference (2MCID): A new twist on an old concept. Acta Dermato Venereologica 98(7), pp. 715-717. (10.2340/00015555-2894)
• Marron, S. E. et al. 2018. The psychosocial burden of hand eczema: Data from a European dermatological multicentre study. Contact Dermatitis (10.1111/cod.12973)

2017

• Ali, F. M., Johns, N., Finlay, A. Y., Salek, M. S. and Piguet, V. 2017. Comparison of the paper-based and electronic versions of the Dermatology Life Quality Index (DLQI): evidence of equivalence. British Journal of Dermatology 177(5), pp. 1306-1315. (10.1111/bjd.15314)
• Ali, F., Cueva, A., Vyas, J., Atwan, A., Salek, M., Finlay, A. and Piguet, V. 2017. A systematic review of the use of quality-of-life instruments in randomised controlled trials of psoriasis. British Journal of Dermatology 176(3), pp. 577-593. (10.1111/bjd.14788)

2015

• Campbell, N., Ali, F., Finlay, A. Y. and Salek, S. S. 2015. Equivalence of electronic and paper-based patient-reported outcome measures. Quality of Life Research 24(8), pp. 1949-1961. (10.1007/s11136-015-0937-3)

2011

• Ali, F., Ingram, J. R., Whatley, S., Badminton, M. N. and Anstey, A. V. 2011. X-linked dominant protoporphyria due to a novel mutation in ALAS2: a case report [Abstract]. British Journal of Dermatology 164(5), pp. 1167-1167. (10.1111/j.1365-2133.2011.10357.x)